Spots Global Cancer Trial Database for anticoagulants
Every month we try and update this database with for anticoagulants cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE) | NCT03099031 | Venous Thromboe... | Tinzaparin | 18 Years - | LEO Pharma | |
| A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE | NCT05171075 | Venous Thromboe... Deep Venous Thr... Pulmonary Embol... | Abelacimab Dalteparin | 18 Years - | Anthos Therapeutics, Inc. | |
| Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism | NCT01164046 | Venous Thromboe... Neoplasms | low molecular w... vitamin K antag... | 18 Years - | University Medical Center Groningen | |
| Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT) | NCT00475098 | Lung Cancer Non Small Cell ... | Tinzaparin sodi... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE | NCT05171049 | Venous Thromboe... Deep Venous Thr... Pulmonary Embol... | Abelacimab Apixaban | 18 Years - | Anthos Therapeutics, Inc. | |
| Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer | NCT04724460 | Venous Thrombos... Neoplasms Anticoagulants | Long DOAC Short DOAC | 20 Years - 80 Years | Kyoto University, Graduate School of Medicine | |
| Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction | NCT00790842 | Multiple Myelom... Plasma Cell Neo... | Lenalidomide Dexamethasone Anticoagulants | 18 Years - | PrECOG, LLC. | |
| Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery | NCT01444612 | Thrombosis, Ven... | dalteparin enoxaparin fondaparinux unfractionated ... | 18 Years - | GlaxoSmithKline | |
| Prophylactic Anticoagulation for Catheter-related Thrombosis | NCT04256525 | Venous Thrombos... Prophylactic An... Patients With T... | Rivaroxaban 10m... Aspirin 100mg low molecule he... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction | NCT00790842 | Multiple Myelom... Plasma Cell Neo... | Lenalidomide Dexamethasone Anticoagulants | 18 Years - | PrECOG, LLC. | |
| Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus | NCT03083782 | Venous Thromboe... Pharmacokinetic... Healthy | Apixaban alone Cyclosporine Tacrolimus Apixaban Apixaban | 18 Years - 55 Years | Thomas Jefferson University | |
| Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate | NCT02822963 | Benign Prostati... Prostate Cancer | 20 Years - | National Cheng-Kung University Hospital | ||
| A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE | NCT05171049 | Venous Thromboe... Deep Venous Thr... Pulmonary Embol... | Abelacimab Apixaban | 18 Years - | Anthos Therapeutics, Inc. | |
| Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism | NCT01164046 | Venous Thromboe... Neoplasms | low molecular w... vitamin K antag... | 18 Years - | University Medical Center Groningen | |
| A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE | NCT05171075 | Venous Thromboe... Deep Venous Thr... Pulmonary Embol... | Abelacimab Dalteparin | 18 Years - | Anthos Therapeutics, Inc. | |
| Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism | NCT01164046 | Venous Thromboe... Neoplasms | low molecular w... vitamin K antag... | 18 Years - | University Medical Center Groningen | |
| Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate | NCT02822963 | Benign Prostati... Prostate Cancer | 20 Years - | National Cheng-Kung University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
